Results 231 to 240 of about 9,798 (259)
Some of the next articles are maybe not open access.

Dantrolene—An Update

1987
Dantrolene sodium, a hydantoin derivative, relaxes skeletal muscle by a peripheral rather than a central action by inhibiting release of calcium from the sarcoplasmic reticulum (SR). Both resting and twitch tensions are decreased in the presence of dantrolene. The action of dantrolene on the SR may be indirect rather than direct.
openaire   +2 more sources

Dantrolene sodium and hepatic injury

Neurology, 1990
This is a report on hepatic adverse events associated with dantrolene therapy. All cases reported to the manufacturer are included, from all sources, through 1987. Of 122 cases containing sufficient data to analyze, 47 patients had asymptomatic transaminase elevations, 12 had additional mild (less than or equal to 2.5 mg/dl) hyperbilirubinemia, 36 had ...
openaire   +3 more sources

Dantrolene Hepatitis-Reply

JAMA: The Journal of the American Medical Association, 1976
The issue raised by Dr Assatourians is what is the most informative and safest procedure in a patient who has total bilirubin levels of 32 mg/100 ml; alkaline phosphatase, 215 IU/100 ml; and SGOT, 260 IU/100 ml. This combination of laboratory abnormalities might well be seen in drug jaundice but is certainly compatible with extrahepatic obstruction ...
openaire   +2 more sources

HEMODYNAMIC INTERACTIONS OF DILTIAZEM-DANTROLENE AND NIFEDIPINE-DANTROLENE

Anesthesiology, 1984
Saltzman Ls   +3 more
openaire   +2 more sources

Could dantrolene be explored as a repurposed drug to treat COVID-19 patients by restoring intracellular calcium homeostasis?

European Review for Medical and Pharmacological Sciences, 2020
B. Jiang, S. Liang, G. Liang, H. Wei
semanticscholar   +1 more source

Hyperkalemia, Verapamil, and Dantrolene

Anesthesiology, 1987
Alexander S. Rubin, Alan D. Zablocki
openaire   +3 more sources

Dantrolene Prophylaxis and Neuromuscular Disorders

Anesthesiology, 1987
Christina T. Mora, James B. Eisenkraft
openaire   +3 more sources

Home - About - Disclaimer - Privacy